PLAY PODCASTS
Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Season 1 · Episode 133

Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption

Nina Deka of ROBO Global shares the main healthcare themes they are tracking and some companies with game-changing solutions.

Investing With IBD

October 7, 202153m 42s

Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Nina Deka, Senior Research Analyst at ROBO Global, points out some huge problems in the healthcare industry that are ripe for innovative solutions. After looking at some of five major themes, Nina revisits some stocks from her last appearance like 1Life Healthcare (ONEM) and Teladoc (TDOC) as well as the stories behind Tabula Rasa (TRHC) Akoya BioSciences (AKYA), Catalent (CTLT), Dexcom (DXCM) and Fate Therapeutics (FATE). For the video version, show notes and charts, visit investors.com/podcast.

Learn more about your ad choices. Visit megaphone.fm/adchoices